基本信息
views: 1
Career Trajectory
Bio
Stjepan Oreskovic is a Zagreb School of Medicine professor and a member of the European Academy of Sciences and Arts.
Among other international research projects, he is the Principal Investigator (PI) for Pfizer's GLOBAL GRAND PROJECT (2017-2023): "Varenicline Versus Cytisine for Smoking Cessation - A Randomized Control Trial" — a head-to-head, non-inferiority trial ( multicentric and multidisciplinary study registered at https://clinicaltrials.gov/ct2/show/NCT04015414) and https://osf.io/hbvsk/ ) comprising teams of clinical, behavioral and data science experts from Harvard Medical School - Massachusetts General Hospital, University of Ljubljana and University of Zagreb Faculty of Medicine. He is a Fellow at Harvard Medical School Department of Global Health & Social Medicine – Center for Bioethics (EXT) and at the Institute of Coaching McLean Hospital Harvard Medical School Associate.
Professor Oreskovic is the founder and director of the World Health Organization Collaborating Centre for HIV Strategic Information (https://www.hivevaluation.org/about-us/), working with experts, scholars, and policymakers from 111 countries educating more than 2600 students in the course of the last 15 years.
He has led a range of educational, research, and consultancy projects and taught at the LSE, the London School of Hygiene and Tropical Medicine, Harvard School of Medicine, HSPH, Bocconi, Trieste, and Ljubljana University, as well as at L'Ecole Nationale de Sante Publique L'université Sorbonne-Paris-Cité.
Professor Oreskovic Co-Chairs the Data Science and the Right to Science Conference ( https://dibss.org/ ), aiming to develop a formatted interdisciplinary dialog between social, behavioral, and life scientists coming from a variety of disciplines (biology, bioinformatics, genetic medicine, and neurosciences, sociology, psychology, bioethics, and philosophy) to discuss, with representatives of international organizations and governments as well as other actors, including civil society movements, research networks, and corporations, the possibility of a new framework for data science, artificial intelligence, machine learning, and its application to health, medical sciences and biotechnological advancements.
He has authored 156 peer-reviewed papers (Google Scholar: H-20 and i10-37 index) with leading global publishers, such as Springer Publishing, Elsevier Science, Wiley-Blackwell, and Pergamon Press. He has co-authored and contributed to 15 books published by John Wiley and Sons, VDM Verlag OmniScriptum, Cambridge University Press, and others.
He also worked as a consultant for international organizations such as The World Bank, the EU Commission, and the World Health Organization.
Professor Oreskovic is best known for his projects fostering innovative healthcare interventions in tobacco control, obesity prevention, internet addiction, and HIV surveillance. His projects were featured in the Lancet and the BMJ and quoted. He has contributed to leading international media, including Bloomberg, Huffington Post, Reuters, CNN, BBC, NBC, and RTL.
Research Interests
Papers共 94 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Croatian medical journalno. 4 (2023): 289-291
Nicotine and Tobacco Researchno. 9 (2023): 1547-1555
Tin Oreskovic,Milan Milosevic, Bruna Kostelac Kosir, Darko Horvat, Tomislav Glavas, Antonio Sadaric, Carin-Isabel Knoop,Stjepan Oreskovic
FRONTIERS IN PSYCHOLOGY (2023): 1258750
FRONTIERS IN PUBLIC HEALTH (2023): 1231796-1231796
Open Access Macedonian Journal of Medical Sciencesno. B (2022): 2166-2171
Croatian Medical Journalno. 4 (2022): 402-403
Zbornik sveučilišta Libertasno. 7 (2022): 49-66
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn